Try our beta test site
1392 studies found for:    "Pneumonia"
Show Display Options
Rank Status Study
21 Completed
Has Results
Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Community Acquired Pneumonia
Condition: Pneumonia
Interventions: Behavioral: Strategy based on BPS guided antibiotic use;   Behavioral: Enforced Guidelines
22 Completed CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients
Condition: Pneumonia
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)
23 Completed Doripenem in the Treatment of Hospital-Acquired Pneumonia
Condition: Pneumonia
Intervention: Drug: doripenem
24 Completed Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
Condition: Pneumonia
Intervention: Drug: Amikacin inhalation solution (BAY41-6551)
25 Completed A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
Condition: Pneumonia
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039);   Drug: Ceftriaxone; Azithromycin; Amoxicilline/clavulanate; Clarithromycin
26 Completed Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: Tigecycline;   Drug: Imipenem;   Drug: Cilastatin
27 Completed Procalcitonin Use in Pneumonia Patients in the Critical Care Setting
Condition: Pneumonia
Intervention: Other: Use of procalcitonin as biomarker to guide therapy
28 Recruiting Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Condition: Pneumonia
Interventions: Drug: Tedizolid phosphate IV;   Drug: Linezolid
29 Withdrawn Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia
Condition: Pneumonia
Intervention:
30 Completed Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
Condition: Pneumonia
Interventions: Other: Fuxiong San;   Drug: Xiyanping injection;   Drug: Ribavirin Injection;   Drug: Xiaoer Qingfei Heji (mixture);   Drug: Zhi Ke San;   Drug: Hua Tan San;   Drug: Guaifenesin Syrup;   Drug: Ibuprofen Suspension;   Drug: salbutamol
31 Completed Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
Condition: Pneumonia
Interventions: Drug: Ceftobiprole medocaril;   Drug: Ceftriaxone with or without Linezolid
32 Terminated Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
Condition: Pneumonia
Interventions: Drug: Ilomedin and Integrilin;   Drug: low molecular weight heparin.
33 Unknown  Zinc as Adjunct to Treatment of Pneumonia
Condition: Pneumonia
Intervention: Dietary Supplement: Zinc sulphate
34 Unknown  Epidemiology of Community Acquired Pneumonia in North Israel
Condition: Community Acquired Pneumonia
Intervention:
35 Recruiting Physiotherapy in Patients Hospitalized Due to Pneumonia.
Condition: Pneumonia
Interventions: Drug: cephalosporin with or without erythromycin;   Other: Physiotherapy program
36 Completed Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children
Condition: Pneumonia
Intervention: Drug: Oral Amoxicillin
37 Terminated Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia
Condition: Pneumonia
Intervention: Drug: iseganan hydrochloride
38 Completed Ceftobiprole in Hospital Acquired Pneumonia
Condition: Pneumonia
Interventions: Drug: ceftobiprole plus placebo;   Drug: linezolid plus ceftazidime
39 Completed Ceftobiprole in Hospital Acquired Pneumonia
Condition: Pneumonia
Interventions: Drug: ceftobiprole plus placebo;   Drug: linezolid plus ceftazidime
40 Active, not recruiting Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia
Condition: Pneumonia
Interventions: Drug: Amoxicillin-Potassium Clavulanate Combination;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.